PARALLAX Trial: Mixed Results With Entresto in HFpEF

(MedPage Today) -- The combination therapy sacubitril/valsartan (Entresto) failed to improve distance in the 6-minute walk test versus individual medical therapy (IMT) in patients with heart failure (HF) marked by preserved ejection fraction (HFpEF...